Načítá se...
Life-Threatening Hemopericardium Associated with Rivaroxaban
Rivaroxaban is a novel oral anticoagulant used in the treatment of venous thromboembolism. The use of this medication has expanded over the recent years with resultant expansion of side effect profile. We present a case of a 56-year-old female who presented with shortness of breath and chest pain 12...
Uloženo v:
| Vydáno v: | Case Rep Cardiol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Hindawi
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5396431/ https://ncbi.nlm.nih.gov/pubmed/28480082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/4691325 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|